This proposal requests continued funding for our Training Program in Cancer Biology. We are requesting continuation of funding for six predoctoral Ph.D. trainees and 4 postdoctoral trainees, as well as funding for one postdoctoral trainee in systems biology, which was piloted in the previous funding cycle through a supplement to this grant. The program is entering its 10th year. The program intensively trains pre- and postdoctoral trainees in the field of cancer biology and provides the skills in experimental approaches so that they can become critical, creative, and independent scientists. Training includes a focus not only on biological relevant issues to cancer initiation, progression and metastases, but also on transdisciplinary approaches using organic chemistry, nanotechnology and systems biology, and includes exposure to clinical issues surrounding cancer diagnosis and treatment. All faculty preceptors have primary or cross appointments in the Department of Cancer Biology of Wake Forest University Health Sciences. Features of the training program include an extensive mentoring and evaluation process and career development activities. This training program addresses the goals of the National Cancer Institute by (1) producing investigators equipped to focus on the cancer problem in their research careers;(2) providing training spanning the chemical- and physical- biological interfaces;(3) emphasizing links between basic science and the clinical problems of patients with cancer. The training program achieved notable successes during the past two funding cycles (1) successful recruitment of minority trainees who entered and successfully completed the training program;(2) cross disciplinary training in new areas of cancer research;(3) a steady rise in the number and quality of applicants, their productivity and their achievements. This training proposal includes an entirely revised and reengineered postdoctoral training program that is responsive to the recent critique and will strengthen our ability to matriculate top quality applicants to our program.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee B - Comprehensiveness (NCI)
Program Officer
Damico, Mark W
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Wake Forest University Health Sciences
Schools of Medicine
United States
Zip Code
Blischak, Paul D; Chifman, Julia; Wolfe, Andrea D et al. (2018) HyDe: A Python Package for Genome-Scale Hybridization Detection. Syst Biol 67:821-829
Swanner, Jessica; Singh, Ravi (2018) Synthesis, Purification, Characterization, and Imaging of Cy3-Functionalized Fluorescent Silver Nanoparticles in 2D and 3D Tumor Models. Methods Mol Biol 1790:209-218
Chmielewski, Jeffrey P; Bowlby, Sarah C; Wheeler, Frances B et al. (2018) CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools. Mol Cancer Res 16:1687-1700
Sirkisoon, Sherona R; Carpenter, Richard L; Rimkus, Tadas et al. (2018) Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer. Oncogene 37:2502-2514
Rimkus, Tadas K; Carpenter, Richard L; Sirkisoon, Sherona et al. (2018) Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44. Cancer Res 78:2589-2600
Chifman, Julia; Arat, Seda; Deng, Zhiyong et al. (2017) Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling Perspective. PLoS Comput Biol 13:e1005352
Nickkholgh, Bita; Sittadjody, Sivanandane; Rothberg, Michael B et al. (2017) Beta-catenin represses protein kinase D1 gene expression by non-canonical pathway through MYC/MAX transcription complex in prostate cancer. Oncotarget 8:78811-78824
Carpenter, Richard L; Sirkisoon, Sherona; Zhu, Dongqin et al. (2017) Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth. Oncotarget 8:73947-73963
Alexander, Peter M; Caudell, David L; Kucera, Gregory L et al. (2017) The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia. PLoS One 12:e0179798
Eldridge, Brittany N; Xing, Fei; Fahrenholtz, Cale D et al. (2017) Evaluation of multiwalled carbon nanotube cytotoxicity in cultures of human brain microvascular endothelial cells grown on plastic or basement membrane. Toxicol In Vitro 41:223-231

Showing the most recent 10 out of 89 publications